Genetic Background Drives Transcriptional Variation in Human Induced Pluripotent Stem Cells
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Human iPS cells have been generated using a diverse range of tissues from a variety of donors using different reprogramming vectors. However, these cell lines are heterogeneous, which presents a limitation for their use in disease modeling and personalized medicine. To explore the basis of this heterogeneity we generated 25 iPS cell lines under normalised conditions from the same set of somatic tissues across a number of donors. RNA-seq data sets from each cell line were compared to identify the majority contributors to transcriptional heterogeneity. We found that genetic differences between individual donors were the major cause of transcriptional variation between lines. In contrast, residual signatures from the somatic cell of origin, so called epigenetic memory, contributed relatively little to transcriptional variation. Thus, underlying genetic background variation is responsible for most heterogeneity between human iPS cell lines. We conclude that epigenetic effects in hIPSCs are minimal, and that hIPSCs are a stable, robust and powerful platform for large-scale studies of the function of genetic differences between individuals. Our data also suggest that future studies using hIPSCs as a model system should focus most effort on collection of large numbers of donors, rather than generating large numbers of lines from the same donor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4 Genetic effects on transcription in iPSCs. (a) Variance component of known eQTL genes showing primary eQTL SNPs being able to explain 17% of FPKM variation on average. Top and bottom 3,000 eQTL genes and SNPs were determined by means of P-values using gEUVADIS RNA-seq data [27]. (b) Box- plot of log2 FPKM aggregated across 462 eQTL genes (FDR 5%) stratified into high (+/+), medium (+/−) and low (−/−) genotypes at the minimum p-value eQTL SNPs ascertained from [2] (FDR 5%). Pearson correlation r = 0.44, p<9.8×10−68. (c) Boxplot of allelic imbalance at high-expression (+) and low-expression (−) haplotypes across all eQTL genes ascertained from [2]. The red line is at 0.5 indicating the expected fraction under the null. Student t p<1.3×10−8. (d) Mean RNA-Seq coverage depth in iPSCs, averaged across all iPSC lines from each individual, at a putative example eQTL for the noncoding RNA SNHG5 gene. Individuals are grouped by their genotype at the putatively causal variant rs1059307. Individual genotypes are shown with the number of RNA-seq samples in parentheses. (e) Average coverage depth of fragments coming from the high-expression haplotype (allele T) and low- expression haplotype (allele G) at rs1059307. (f) eQTL association of SNHG5 gene at rs1059307 in lymphoblastoid cell lines from [2] showing distributions of log2 FPKM against SNP genotypes at rs1059307. The red line shows the best-fit linear regression line.](https://figures.cochat.ai/paper-figures/96597e1d7aa9463aababb4bb7d7946f0/genetic-background-drives-transcriptional-variation-in-human-induced-pluripotent-figure-4.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Reprogramming, for example, a given somatic cell type from a given donor, using a given reprogramming method and culture platform, may give rise to iPSC colonies that are different in their expansion rate, robustness (the tendency to spontaneously differentiate in culture), and potential to be differentiated directly to specific lineages [56,57,58,59,60].”
From Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies (2023) · cites this paper as [59]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Nevertheless, keeping the above parameters the same still results in iPSC colonies that are different from each other.”
From Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies (2023) · cites this paper as [59]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast gapped-read alignment with Bowtie 2
Langmead, B., & Salzberg, S. L. (2012) · Nature Methods · doi:10.1038/nmeth.1923 · Cited by 56,400 · cited 2×
“We mapped reads to assembly h37 of the human genome using Bowtie2 [14] and constructed spliced alignments using Tophat2 [15].”
MethodInduction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Differential expression analysis for sequence count data
Anders, S., & Huber, W. (2010) · Genome Biology · doi:10.1186/gb-2010-11-10-r106 · Cited by 15,581
Trapnell, C., Williams, B. A., Pertea, G., Mortazavi, A., Kwan, G., van Baren, M. J., Salzberg, S. L., Wold, B. J., & Pachter, L. (2010) · Nature Biotechnology · doi:10.1038/nbt.1621 · Cited by 15,556
Kim, D., Pertea, G., Trapnell, C., Pimentel, H., Kelley, R., & Salzberg, S. L. (2013) · Genome Biology · doi:10.1186/gb-2013-14-4-r36 · Cited by 12,668 · cited 1×
“We mapped reads to assembly h37 of the human genome using Bowtie2 [14] and constructed spliced alignments using Tophat2 [34] with default settings.”
MethodTopHat: discovering splice junctions with RNA-Seq
Trapnell, C., Pachter, L., & Salzberg, S. L. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp120 · Cited by 11,617
Principal components analysis corrects for stratification in genome-wide association studies
Price, A. L., Patterson, N. J., Plenge, R. M., Weinblatt, M. E., Shadick, N. A., & Reich, D. (2006) · Nature Genetics · doi:10.1038/ng1847 · Cited by 10,248 · cited 1×
“Principal component analysis was performed using Eigenstrat [35] with genome-wide SNP genotypes of European populations obtained from 1000 Genomes Project.”
MethodEpigenetic memory in induced pluripotent stem cells
Kim, K., Doi, A., Wen, B., Ng, K., Zhao, R., Cahan, P., Kim, J., Aryee, M. J., Ji, H., Ehrlich, L. I. R., et al. (2010) · Nature · doi:10.1038/nature09342 · Cited by 2,313 · cited 1×
“We note, however, that other studies that have also explicitly controlled for genetic background still report some variation in transcription, methylation and differentiation efficiencies that appear to arise from cell type of origin effects [5,8,10].”
ResultTranscriptome and genome sequencing uncovers functional variation in humans
The Geuvadis Consortium, Lappalainen, T., Sammeth, M., Friedländer, M. R., ‘t Hoen, P. A. C., Monlong, J., Rivas, M. A., Gonzàlez-Porta, M., Kurbatova, N., Griebel, T., et al. (2013) · Nature · doi:10.1038/nature12531 · Cited by 1,888 · cited 2×
“Top and bottom 3,000 eQTL genes and SNPs were determined by means of P-values using gEUVADIS RNA-seq data [27].”
MethodBrowning, B. L., & Browning, S. R. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.01.005 · Cited by 1,640 · cited 2×
“5-8 BeadChip, followed by imputation with the 1000 Genomes Project data and haplotype phasing using Beagle software [5].”
Method
Cited by
The role of regulatory variation in complex traits and disease
Albert, F. W., & Kruglyak, L. (2015) · Nature Reviews Genetics · doi:10.1038/nrg3891 · Cited by 1,047
variancePartition: interpreting drivers of variation in complex gene expression studies
Hoffman, G. E., & Schadt, E. E. (2016) · BMC Bioinformatics · doi:10.1186/s12859-016-1323-z · Cited by 769
“[4] examined how multiple dimensions of variation a ect expression variation in human induced pluripotent stem cells.”
Common genetic variation drives molecular heterogeneity in human iPSCs
Kilpinen, H., Goncalves, A., Leha, A., Afzal, V., Alasoo, K., Ashford, S., Bala, S., Bensaddek, D., Casale, F. P., Culley, O. J., et al. (2017) · Nature · doi:10.1038/nature22403 · Cited by 586
Self-citationThe rise of three-dimensional human brain cultures
Pașca, S. P. (2018) · Nature · doi:10.1038/nature25032 · Cited by 499
Induced Pluripotent Stem Cells Meet Genome Editing
Hockemeyer, D., & Jaenisch, R. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.04.013 · Cited by 499
“…state are at best small and overshadowed by differences caused by the reprograming method of choice, cell selection during propagation, culture conditions, and more importantly genetic background of the parental somatic cell (Guenther et al., 2010; (Kyttala et al., 2016); (Rouhani et al., 2014)).”
BackgroundCurrent Challenges of iPSC-Based Disease Modeling and Therapeutic Implications
Doss, M. X., & Sachinidis, A. (2019) · Cells · doi:10.3390/cells8050403 · Cited by 456
“Although it has been documented that each ESC line has its own clonal differences, iPSC lines show greater diversity than ESCs due to the residual epigenetic memory, genetic background and the characteristics acquired during reprogramming and differentiation [62,63,96].”
BackgroundVolpato, V., & Webber, C. (2020) · Disease Models & Mechanisms · doi:10.1242/dmm.042317 · Cited by 379
“This was highlighted at different levels with inter-individual variation detected in gene expression and eQTLs (Carcamo-Orive et al., 2017; Rouhani et al., 2014; Thomas et al., 2015), and in DNA methylation (Burrows et al., 2016).”
Vitale, I., Manic, G., De Maria, R., Kroemer, G., & Galluzzi, L. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.04.006 · Cited by 361
“…load, partially reflecting the somatic mutations of differentiated cells from which they derive (Tapia and Schöler, 2016). iPSCs also display high epigenetic and transcriptional variability as a consequence of the genetic background of the donor (Choi et al., 2015; Rouhani et al., 2014).”
BackgroundA comparison of genetically matched cell lines reveals the equivalence of human iPSCs and ESCs
Choi, J., Lee, S., Mallard, W., Clement, K., Tagliazucchi, G. M., Lim, H., Choi, I. Y., Ferrari, F., Tsankov, A. M., Pop, R., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3388 · Cited by 281
Carcamo-Orive, I., Hoffman, G. E., Cundiff, P., Beckmann, N. D., D’Souza, S. L., Knowles, J. W., Patel, A., Hendry, C., Papatsenko, D., Abbasi, F., et al. (2017) · Cell Stem Cell · doi:10.1016/j.stem.2016.11.005 · Cited by 263
Kyttälä, A., Moraghebi, R., Valensisi, C., Kettunen, J., Andrus, C., Pasumarthy, K. K., Nakanishi, M., Nishimura, K., Ohtaka, M., Weltner, J., et al. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.12.009 · Cited by 257
“This is well in line with recent studies that have suggested the influence of genetic background on transcription (Rouhani et al., 2014; Shao et al., 2013) and differentiation of iPSC lines (Kajiwara et al.”
BackgroundResultInfluentialModeling of fibrotic lung disease using 3D organoids derived from human pluripotent stem cells
Strikoudis, A., Cieślak, A., Loffredo, L., Chen, Y.-W., Patel, N., Saqi, A., Lederer, D. J., & Snoeck, H.-W. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.077 · Cited by 242
Molecular and functional variation in iPSC-derived sensory neurons
HIPSCI Consortium, Schwartzentruber, J., Foskolou, S., Kilpinen, H., Rodrigues, J., Alasoo, K., Knights, A. J., Patel, M., Goncalves, A., Ferreira, R., et al. (2018) · Nature Genetics · doi:10.1038/s41588-017-0005-8 · Cited by 223
Self-citationPresent and future challenges of induced pluripotent stem cells
Ohnuki, M., & Takahashi, K. (2015) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2014.0367 · Cited by 174
Matsa, E., Burridge, P. W., Yu, K.-H., Ahrens, J. H., Termglinchan, V., Wu, H., Liu, C., Shukla, P., Sayed, N., Churko, J. M., et al. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.07.006 · Cited by 164
“…between individual donors were the major cause of transcriptional variation among undifferentiated hiPSC lines, whereas other contributors such as cell type of origin and reprograming strategy had minimal effects on transcriptional heterogeneity (Choi et al., 2015; Rouhani et al., 2014).”
BackgroundMethodPanopoulos, A. D., D'Antonio, M., Benaglio, P., Williams, R., Hashem, S. I., Schuldt, B. M., DeBoever, C., Arias, A. D., Garcia, M., Nelson, B. C., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.03.012 · Cited by 169
“We and others have recently shown that genetic differences between individuals are associatedwith a variety ofmolecular phenotypes in iPSCs, including the transcriptome and epigenome (Burrows et al., 2016; DeBoever et al., 2017; Panopoulos et al., 2017; Rouhani et al., 2014; Thomas et al., 2015), but it is still uncle…”
BackgroundHuman-specific genetics: new tools to explore the molecular and cellular basis of human evolution
Pollen, A. A., Kilik, U., Lowe, C. B., & Camp, J. G. (2023) · Nature Reviews Genetics · doi:10.1038/s41576-022-00568-4 · Cited by 153
DeBoever, C., Li, H., Jakubosky, D., Benaglio, P., Reyna, J., Olson, K. M., Huang, H., Biggs, W., Sandoval, E., D’Antonio, M., et al. (2017) · Cell Stem Cell · doi:10.1016/j.stem.2017.03.009 · Cited by 157
“…expression in iPSCs, but only recently have sufficiently large collections of iPSCs with corresponding genotype and gene expression data become available that enable genotype-expression association studies (Banovich et al., 2016; Kilpinen et al., 2016; Rouhani et al., 2014; Thomas et al., 2015).”
InfluentialPatient-derived induced pluripotent stem cells in cancer research and precision oncology
Papapetrou, E. P. (2016) · Nature Medicine · doi:10.1038/nm.4238 · Cited by 160
Schaefer, M., Kapoor, U., & Jantsch, M. F. (2017) · Open Biology · doi:10.1098/rsob.170077 · Cited by 172
Pluripotent stem cell-based therapy for Parkinson’s disease: Current status and future prospects
Sonntag, K.-C., Song, B., Lee, N., Jung, J. H., Cha, Y., Leblanc, P., Neff, C., Kong, S. W., Carter, B. S., Schweitzer, J., et al. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.04.005 · Cited by 143
Molecular Obstacles to Clinical Translation of iPSCs
Tapia, N., & Schöler, H. R. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.06.017 · Cited by 141
“These authors showed that hiPSC lines derived from different tissues of the same individual are more similar than hiPSC lines derived from the same donor cell type of different individuals (Rouhani et al., 2014).”
BackgroundBest Practices for Translational Disease Modeling Using Human iPSC-Derived Neurons
Engle, S. J., Blaha, L., & Kleiman, R. J. (2018) · Neuron · doi:10.1016/j.neuron.2018.10.033 · Cited by 142
Burrows, C. K., Banovich, N. E., Pavlovic, B. J., Patterson, K., Gallego Romero, I., Pritchard, J. K., & Gilad, Y. (2016) · PLOS Genetics · doi:10.1371/journal.pgen.1005793 · Cited by 131
“[23] where a similar study design was employed examining only gene expression levels.”
BackgroundMethodResultInfluentialInsights into pancreatic islet cell dysfunction from type 2 diabetes mellitus genetics
Krentz, N. A. J., & Gloyn, A. L. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0325-0 · Cited by 138
Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells
Mungenast, A. E., Siegert, S., & Tsai, L.-H. (2016) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2015.11.010 · Cited by 127
Mossink, B., Verboven, A. H. A., van Hugte, E., Gunnewiek, T. M. K., Parodi, G., Linda, K., Schoenmaker, C., Kleefstra, T., Kozicz, T., van Bokhoven, H., et al. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.07.001 · Cited by 147
“Indeed, previous literature uncovered that the heterogeneity within 25 different hiPSC lines on a transcriptional level was due to differences in genetic background (Rouhani et al. 2014).”
BackgroundSalomonis, N., Dexheimer, P. J., Omberg, L., Schroll, R., Bush, S., Huo, J., Schriml, L., Ho Sui, S., Keddache, M., Mayhew, C., et al. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.05.006 · Cited by 128
“…and epigenetic stability of hESC and iPSC including lines generated using different strategies, distinct parental somatic cell types, or reprogramming methods (Bock et al., 2011; International Stem Cell Initiative et al., 2007; Müller et al., 2011; Rouhani et al., 2014; Schlaeger et al., 2015).”
BackgroundMethodSürün, D., Schneider, A., Mircetic, J., Neumann, K., Lansing, F., Paszkowski-Rogacz, M., Hänchen, V., Lee-Kirsch, M. A., & Buchholz, F. (2020) · Genes · doi:10.3390/genes11050511 · Cited by 120
“A major challenge of using patient-derived hiPSCs for modeling human diseases is their genetic diversity and differences in epigenetic memory [11,12].”
BackgroundImpact of regulatory variation across human iPSCs and differentiated cells
Banovich, N. E., Li, Y. I., Raj, A., Ward, M. C., Greenside, P., Calderon, D., Tung, P. Y., Burnett, J. E., Myrthil, M., Thomas, S. M., et al. (2018) · Genome Research · doi:10.1101/gr.224436.117 · Cited by 128
Bobis‐Wozowicz, S., Kmiotek‐Wasylewska, K., Sekuła, M., Kędracka–Krok, S., Kamycka, E., Adamiak, M., Jankowska, U., Madetko‐Talowska, A., Sarna, M., Bik-Multanowski, M., et al. (2015) · Stem Cells · doi:10.1002/stem.2078 · Cited by 124
Therapeutic strategies for spinal muscular atrophy: SMN and beyond
Bowerman, M., Becker, C. G., Yáñez‐Muñoz, R. J., Ning, K., Wood, M. J. A., Gillingwater, T. H., & Talbot, K. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.030148 · Cited by 137
“…hold a lot of promise, experimental caveats include heterogeneity of the cell populations derived, as well as the limitations of studying cells in culture, isolated from other tissues within the context of the whole organism (Rouhani et al., 2014; De Filippis et al., 2017; Ebert et al., 2012).”
BackgroundVariability of human pluripotent stem cell lines
Ortmann, D., & Vallier, L. (2017) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2017.07.004 · Cited by 117
Self-citationWhitmore, S. S., Wagner, A. H., DeLuca, A. P., Drack, A. V., Stone, E. M., Tucker, B. A., Zeng, S., Braun, T. A., Mullins, R. F., & Scheetz, T. E. (2014) · Experimental Eye Research · doi:10.1016/j.exer.2014.11.001 · Cited by 120
“Hierarchical clustering of samples showed clear separation of neural retina from RPE/ choroid samples and evidence of donor effect, i.e., samples derived from the same donor tend to cluster together more often than not (Figure 1) (Rouhani et al., 2014).”
BackgroundA developmental framework for induced pluripotency
Takahashi, K., & Yamanaka, S. (2015) · Development · doi:10.1242/dev.114249 · Cited by 111
“However, many others have demonstrated that there are no differences between ESCs and iPSCs, including their somatic epigenetic memory (Guenther et al., 2010; Newman and Cooper, 2010; Bock et al., 2011; Rouhani et al., 2014).”
BackgroundiPSC Preparation and Epigenetic Memory: Does the Tissue Origin Matter?
Scesa, G., Adami, R., & Bottai, D. (2021) · Cells · doi:10.3390/cells10061470 · Cited by 110
“In contrast, inter-individual genetic variation was responsible for 38% of the total, with <1% attributable to differences between iPSCs and ESCs [121].”
BackgroundMutational History of a Human Cell Lineage from Somatic to Induced Pluripotent Stem Cells
Rouhani, F. J., Nik-Zainal, S., Wuster, A., Li, Y., Conte, N., Koike-Yusa, H., Kumasaka, N., Vallier, L., Yusa, K., & Bradley, A. (2016) · PLOS Genetics · doi:10.1371/journal.pgen.1005932 · Cited by 112
“The majority of the iPSCs used in this study have been previously characterised in other publications [12,13].”
MethodSelf-citationEditing the genome of hiPSC with CRISPR/Cas9: disease models
Bassett, A. R. (2017) · Mammalian Genome · doi:10.1007/s00335-017-9684-9 · Cited by 109
Rouhani, F. J., Zou, X., Danecek, P., Badja, C., Amarante, T. D., Koh, G., Wu, Q., Memari, Y., Durbin, R., Martincorena, I., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01147-3 · Cited by 105
Self-citationMatsa, E., Ahrens, J. H., & Wu, J. C. (2016) · Physiological Reviews · doi:10.1152/physrev.00036.2015 · Cited by 105
Reduced MEK inhibition preserves genomic stability in naive human embryonic stem cells
Stefano, B. D., Ueda, M., Sabri, S., Brumbaugh, J., Huebner, A. J., Sahakyan, A., Clement, K., Clowers, K. J., Erickson, A. R., Shioda, K., et al. (2018) · Nature Methods · doi:10.1038/s41592-018-0104-1 · Cited by 108
Alasoo, K., Martinez, F. O., Hale, C., Gordon, S., Powrie, F., Dougan, G., Mukhopadhyay, S., & Gaffney, D. J. (2015) · Scientific Reports · doi:10.1038/srep12524 · Cited by 102
Self-citationAutologous Pluripotent Stem Cell–Derived β-Like Cells for Diabetes Cellular Therapy
Millman, J. R., & Pagliuca, F. W. (2017) · Diabetes · doi:10.2337/db16-1406 · Cited by 99
“Patient-to-patient variation in hiPSCs exists because of differences in genetic background, which influences hiPSC gene expression and methylation state (58,59) and likely influences differentiation to b-like cells.”
BackgroundWheeler, H. E., Wing, C., Delaney, S. M., Komatsu, M., & Dolan, M. E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118020 · Cited by 105
“A recent study demonstrated that genetic background was the major cause of transcriptional variation among iPSC lines, suggesting that future studies should focus on collection of a large number of donors, rather than generating large numbers of lines from the same donor [47].”
Germain, P.-L., & Testa, G. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.05.012 · Cited by 94
“The predominance of inter-individual differences in explaining transcriptional variability has already been reported (Rouhani et al., 2014; Burrows et al., 2016; Carcamo-Orive et al., 2016).”
BackgroundTransient naive reprogramming corrects hiPS cells functionally and epigenetically
Buckberry, S., Liu, X., Poppe, D., Tan, J. P., Sun, G., Chen, J., Nguyen, T. V., de Mendoza, A., Pflueger, J., Frazer, T., et al. (2023) · Nature · doi:10.1038/s41586-023-06424-7 · Cited by 95
Modeling psychiatric disorders: from genomic findings to cellular phenotypes
Falk, A., Heine, V. M., Harwood, A. J., Sullivan, P. F., Peitz, M., Brüstle, O., Shen, S., Sun, Y.-M., Glover, J. C., Posthuma, D., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.89 · Cited by 84
Need for high-resolution Genetic Analysis in iPSC: Results and Lessons from the ForIPS Consortium
Popp, B., Krumbiegel, M., Grosch, J., Sommer, A., Uebe, S., Kohl, Z., Plötz, S., Farrell, M., Trautmann, U., Kraus, C., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-35506-0 · Cited by 81
Ho, S.-M., Hartley, B. J., Flaherty, E., Rajarajan, P., Abdelaal, R., Obiorah, I., Barretto, N., Muhammad, H., Phatnani, H. P., Akbarian, S., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.06.012 · Cited by 84
“As extensive transcriptional variability exists between hiPSCs from different donors (Carcamo-Orive et al., 2017; Nishizawa et al., 2016; Rouhani et al., 2014), we first considered how well the activating capabilities of both platforms translated across five genes (Figure 1C) using neural cells…”
BackgroundMapping genetic effects on cellular phenotypes with “cell villages”
Mitchell, J. M., Nemesh, J., Ghosh, S., Handsaker, R. E., Mello, C. J., Meyer, D., Raghunathan, K., de Rivera, H., Tegtmeyer, M., Hawes, D., et al. (2020) · doi:10.1101/2020.06.29.174383 · Cited by 63
“Finally, a central challenge to the maintenance and expansion of cellular resource banks that are required to facilitate population-scale experiments has been detecting cell line contamination and validating of donor identity (Liang and Zhang, 2013, Rouhani et al., 2014).”
BackgroundThermotolerant coral symbionts modulate heat stress‐responsive genes in their hosts
Cunning, R., & Baker, A. C. (2020) · Molecular Ecology · doi:10.1111/mec.15526 · Cited by 87
Corneal cell therapy: with iPSCs, it is no more a far-sight
Chakrabarty, K., Shetty, R., & Ghosh, A. (2018) · Stem cell research & therapeutics · doi:10.1186/s13287-018-1036-5 · Cited by 65
Zhao, M.-T., Chen, H., Liu, Q., Shao, N.-Y., Sayed, N., Wo, H.-T., Zhang, J. Z., Ong, S.-G., Liu, C., Kim, Y., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1708991114 · Cited by 78
Hu, S., Zhao, M.-T., Jahanbani, F., Shao, N.-Y., Lee, W. H., Chen, H., Snyder, M. P., & Wu, J. C. (2016) · JCI Insight · doi:10.1172/jci.insight.85558 · Cited by 73
“Recent studies have shown that human iPSCs are equivalent to genetically matched ESCs, and genetic background primarily contributes to the transcriptional variations seen among human ESCs and iPSCs (19, 20).”
BackgroundExpression quantitative trait locus analysis for translational medicine
Gibson, G. C., Powell, J. E., & Marigorta, U. M. (2015) · Genome Medicine · doi:10.1186/s13073-015-0186-7 · Cited by 85
“Another possible approach will be the differentiation of induced pluripotent stem cells from cases and controls [71], although there is no guarantee that this will generate expression profiles that mirror the pathological state in patients.”
BackgroundA reversible haploid mouse embryonic stem cell biobank resource for functional genomics
Elling, U., Wimmer, R. A., Leibbrandt, A., Burkard, T., Michlits, G., Leopoldi, A., Micheler, T., Abdeen, D., Zhuk, S., Aspalter, I. M., et al. (2017) · Nature · doi:10.1038/nature24027 · Cited by 75
Findley, A. S., Monziani, A., Richards, A. L., Rhodes, K., Ward, M. C., Kalita, C. A., Alazizi, A., Pazokitoroudi, A., Sankararaman, S., Wen, X., et al. (2021) · eLife · doi:10.7554/elife.67077 · Cited by 74
Segeritz, C.-P., Rashid, S. T., de Brito, M. C., Serra, M. P., Ordonez, A., Morell, C. M., Kaserman, J. E., Madrigal, P., Hannan, N. R. F., Gatto, L., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.05.028 · Cited by 68
Self-citationRoost, M. S., Slieker, R. C., Bialecka, M., van Iperen, L., Gomes Fernandes, M. M., He, N., Suchiman, H. E. D., Szuhai, K., Carlotti, F., de Koning, E. J. P., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01077-3 · Cited by 65
New considerations for hiPSC-based models of neuropsychiatric disorders
Hoffman, G. E., Schrode, N., Flaherty, E., & Brennand, K. J. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0029-1 · Cited by 66
A causal role for TRESK loss of function in migraine mechanisms
Pettingill, P., Weir, G. A., Wei, L., Wu, Y., Flower, G., Lalic, T., Handel, A. E., Duggal, G., Chintawar, S., Cheung, J., et al. (2019) · Brain · doi:10.1093/brain/awz342 · Cited by 69
“the subsequent phenotypes of the differentiated cells (Rouhani et al., 2014).”
BackgroundPopulation-scale proteome variation in human induced pluripotent stem cells
(2020) · doi:10.7554/elife.57390 · Cited by 59
Self-citationUrine-Derived Stem Cells: The Present and the Future
Ji, X., Wang, M., Chen, F., & Zhou, J. (2017) · Stem Cells International · doi:10.1155/2017/4378947 · Cited by 59
“Several researchers have demonstrated that iPSCs reprogrammed from different original somatic cells includingUDSCsexhibiteddistinct transcriptional and epigenetic patterns, as well as various in vitro differentiation potentials [58, 59].”
BackgroundYang, X., Chen, D., Sun, Q., Wang, Y., Xia, Y., Yang, J., Lin, C., Dang, X., Cen, Z., Liang, D., et al. (2023) · Cell Discovery · doi:10.1038/s41421-023-00543-1 · Cited by 70
Ewoldt, J. K., DePalma, S. J., Jewett, M. E., Karakan, M. Ç., Lin, Y.-M., Hashemian, P. M., Gao, X., Lou, L., McLellan, M. A., Tabares, J., et al. (2024) · Nature Methods · doi:10.1038/s41592-024-02480-7 · Cited by 70
“…has been shown that the genetic background of hiPSC lines impacts the maintenance of hiPSC pluripotency 36 and influences transcriptional variation 37 , which could ultimately impact the differentiation and function of derived hiPSC-CMs 38 , highlighting the importance of including hiPSCs from…”
Wang, T., Zhang, J., Liao, J., Zhang, F., & Zhou, G. (2020) · Stem Cells Translational Medicine · doi:10.1002/sctm.20-0155 · Cited by 64
“One previous study reported that 25 human iPSC lines were constructed from the same set of somatic tissues derived from different individuals.(10) Single-cell RNA-sequencing (RNA-seq) was per-”
BackgroundMerkle, F. T., Ghosh, S. D., Genovese, G., Handsaker, R. E., Kashin, S., Meyer, D., Karczewski, K. J., O’Dushlaine, C. T., Pato, C. N., Pato, M. T., et al. (2022) · Cell stem cell · doi:10.1016/j.stem.2022.01.011 · Cited by 59
“hESCs are predominantly European and often share sibling relationships Genetic background can be an important modifier of cellular phenotypes (Rouhani et al., 2014; Sittig et al., 2016).”
BackgroundPower and optimal study design in iPSC-based brain disease modelling
Brunner, J. W., Lammertse, H. C. A., van Berkel, A. A., Koopmans, F., Li, K. W., Smit, A. B., Toonen, R. F., Verhage, M., & van der Sluis, S. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01866-3 · Cited by 49
“Consequently, several studies conclude that iPSC-based studies benefit from including more donors, rather than more clonal iPSC lines from the same individual [21, 22, 29, 31, 35, 36].”
BackgroundChurko, J. M., Lee, J., Ameen, M., Gu, M., Venkatasubramanian, M., Diecke, S., Sallam, K., Im, H., Wang, G., Gold, J. D., et al. (2017) · Nature Biomedical Engineering · doi:10.1038/s41551-017-0141-6 · Cited by 50
Naive Pluripotent Stem Cells Exhibit Phenotypic Variability that Is Driven by Genetic Variation
Ortmann, D., Brown, S. E., Czechanski, A., Aydin, S., Muraro, D., Huang, Y., Tomaz, R. A., Osnato, A., Canu, G., Wesley, B. T., et al. (2020) · Cell stem cell · doi:10.1016/j.stem.2020.07.019 · Cited by 56
“Several studies have shown that variations in transcriptome profiles are more prominent among lines derived from different donors (DeBoever et al., 2017; Rouhani et al., 2014), and large-scale studies have identified candidate expression quantitative trait loci (eQTL) that could induce phenotypic divergence of hPSC li…”
BackgroundResultSelf-citationMaguire, E. M., Xiao, Q., & Xu, Q. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.309196 · Cited by 51
“retain the patients’ genetic background, a vital component for studying genetic diseases.(71) Thus, the risk of missing impor-”
BackgroundKeller, A., Dziedzicka, D., Zambelli, F., Markouli, C., Sermon, K., Spits, C., & Geens, M. (2018) · Human Reproduction Update · doi:10.1093/humupd/dmx042 · Cited by 51
Wesolowska-Andersen, A., Jensen, R. R., Alcántara, M. P., Beer, N. L., Duff, C., Nylander, V., Gosden, M., Witty, L., Bowden, R., McCarthy, M. I., et al. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.11.010 · Cited by 49
Urine-derived cells provide a readily accessible cell type for feeder-free mRNA reprogramming
Gaignerie, A., Lefort, N., Rousselle, M., Forest, V. F., Flippe, L., François-Campion, V., Girardeau, A., Caillaud, A., Chariau, C., Francheteau, Q., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-32645-2 · Cited by 59
Berry, B. J., Smith, A. S. T., Young, J. E., & Mack, D. L. (2018) · Cells Tissues Organs · doi:10.1159/000493018 · Cited by 48
“However, this same study, along with others [Rouhani et al., 2014], has highlighted that donor-related variability can influence expression of lineage-priming genes in iPSCs.”
ResultThe Epigenetic Reprogramming Roadmap in Generation of iPSCs from Somatic Cells
Brix, J., Zhou, Y., & Luo, Y. (2015) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2015.10.001 · Cited by 55
Concise Review: Making and Using Clinically Compliant Pluripotent Stem Cell Lines
Carpenter, M. K., & Rao, M. S. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0202 · Cited by 47
Zhu, L., Gómez-Durán, A., Saretzki, G. C., Jin, S., Tilgner, K., Melguizo‐Sanchis, D., Anyfantis, G., Al-Aama, J. Y., Vallier, L., Chinnery, P. F., et al. (2016) · The Journal of Cell Biology · doi:10.1083/jcb.201601061 · Cited by 49
Self-citationMarei, H. E. S., Althani, A., Lashen, S., Cenciarelli, C., & Hasan, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-17882-1 · Cited by 53
Swartz, E. W., Baek, J., Pribadi, M., Wojta, K. J., Almeida, S., Karydas, A., Gao, F., Miller, B. L., & Coppola, G. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0340 · Cited by 50
Drug discovery using induced pluripotent stem cell models of neurodegenerative and ocular diseases
Hung, S. S. C., Khan, S., Lo, C. Y.-W., Hewitt, A. W., & Wong, R. C. B. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.026 · Cited by 49
Transplantation of iPSC-TM stimulates division of trabecular meshwork cells in human eyes
Zhu, W., Godwin, C. R., Cheng, L. Z., Scheetz, T. E., & Kuehn, M. H. (2020) · Scientific Reports · doi:10.1038/s41598-020-59941-0 · Cited by 45
Dental stem cells: a future asset of ocular cell therapy
Yam, G. H., Peh, G. S. L., Singhal, S., Goh, B. T., & Mehta, J. S. (2015) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2015.16 · Cited by 44
“Another major concern is that iPSCs retain the intrinsic memory of the original tissue and this may cause the cells to work incorrectly as pluripotent cells and affect the eventual functionality of the desired differentiated cell type (Refs 14, 15).”
A high-content platform to characterise human induced pluripotent stem cell lines
Leha, A., Moens, N., Meleckyte, R., Culley, O. J., Gervasio, M. K., Kerz, M., Reimer, A., Cain, S. A., Streeter, I., Folarin, A., et al. (2016) · Methods · doi:10.1016/j.ymeth.2015.11.012 · Cited by 44
“Heterogeneity in gene expression has been described within a specific iPSC line [2], between different donors [3,4] and through the reprogramming process [5,6].”
BackgroundTracing Early Neurodevelopment in Schizophrenia with Induced Pluripotent Stem Cells
Ahmad, R., Sportelli, V., Ziller, M. J., Spengler, D., & Hoffmann, A. (2018) · Cells · doi:10.3390/cells7090140 · Cited by 46
Slembrouck-Brec, A., Rodrigues, A., Rabesandratana, O., Gagliardi, G., Nanteau, C., Fouquet, S., Thuret, G., Reichman, S., Orieux, G., & Goureau, O. (2019) · Stem Cells International · doi:10.1155/2019/7858796 · Cited by 49
Lupo, K. B., Moon, J.-I., Chambers, A. M., & Matosevic, S. (2021) · Cytotherapy · doi:10.1016/j.jcyt.2021.05.001 · Cited by 42
Induced Pluripotent Stem Cells in Disease Modeling and Gene Identification
Kumar, S., Blangero, J., & Curran, J. E. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7471-9_2 · Cited by 45
O’Regan, G. C., Farag, S. H., Casey, C. S., Wood‐Kaczmar, A., Pocock, J. M., Tabrizi, S. J., & André, R. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02147-6 · Cited by 49
Thomas, D., Shenoy, S., & Sayed, N. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.607364 · Cited by 39
“This suggests that although reprogramming erases most epigenetic modifications, some tissue-specific signatures may remain unaltered and thereby influence cardiac differentiation potential (Kim et al., 2011; Rouhani et al., 2014).”
BackgroundLépine, S., Nauleau-Javaudin, A., Deneault, É., Chen, C. X. ‐., Abdian, N., Franco-Flores, A. K., Haghi, G., Castellanos‐Montiel, M. J., Maussion, G., Chaineau, M., et al. (2024) · iScience · doi:10.1016/j.isci.2024.109166 · Cited by 40
“46,47 Furthermore, a knock-in strategy enables the study of these mutations in the homozygous state, which may produce stronger phenotypes than in the heterozygous state.”
BackgroundJeon, J., Cha, Y., Hong, Y. J., Lee, I., Jang, H., Ko, S., Naumenko, S., Kim, M., Ryu, H. L., Shrestha, Z., et al. (2025) · Cell stem cell · doi:10.1016/j.stem.2025.01.006 · Cited by 45
From Genetic Association to Molecular Mechanisms for Islet-cell Dysfunction in Type 2 Diabetes
Mattis, K. K., & Gloyn, A. L. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.12.045 · Cited by 41
Neural organoids for disease phenotyping, drug screening and developmental biology studies
Hartley, B. J., & Brennand, K. J. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2016.10.004 · Cited by 38
“, 2012), the donor's genetic (Rouhani et al., 2014) and epigenetic (Nishizawa et al.”
BackgroundPanopoulos, A. D., Smith, E. N., Arias, A. D., Shepard, P. J., Hishida, Y., Modesto, V., Diffenderfer, K. E., Conner, C., Biggs, W., Sandoval, E., et al. (2017) · Cell stem cell · doi:10.1016/j.stem.2017.03.010 · Cited by 42
“Other studies have suggested that genetic variation is an important regulator of gene expression and DNA methylation, as well as aberrant methylation in iPSCs (Burrows et al., 2016; Kytt€ al€ a et al., 2016; Rouhani et al., 2014).”
InfluentialSoares, F. A. C., Sheldon, M., Rao, M., Mummery, C., & Vallier, L. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.11.006 · Cited by 37
“An important issue discussed in the workshops was the nature of controls and how to avoid misinterpretation associated with natural variability (or noise) between different hiPSC lines (Rouhani et al., 2014).”
BackgroundSelf-citationModelling Sporadic Alzheimer’s Disease Using Induced Pluripotent Stem Cells
Rowland, H. A., Hooper, N. M., & Kellett, K. A. B. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2663-z · Cited by 40
Yin, X., Li, Q., Shu, Y., Wang, H., Thomas, B., Maxwell, J. T., & Zhang, Y. (2024) · Journal of Biomedical Science · doi:10.1186/s12929-024-01035-4 · Cited by 45
“While u-iPSCs can effectively differentiate into various cell lineages, they show a stronger propensity towards renal and epithelial cell types with tight junction and barrier function, indicating a nuanced view of epigenetic memory in u-iPSCs [148, 149].”
BackgroundMelguizo-Sanchis, D., Xu, Y., Taheem, D., Yu, M., Tilgner, K., Barta, T., Gassner, K., Anyfantis, G., Wan, T., Elango, R., et al. (2018) · Cell Death & Disease · doi:10.1038/s41419-017-0141-1 · Cited by 36
Xie, Y., Ng, N. N., Safrina, O., Ramos, C. M., Ess, K. C., Schwartz, P. H., Smith, M. A., & O’Dowd, D. K. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104627 · Cited by 36
Metadata
- Authors
- Rouhani, F., Kumasaka, N., de Brito, M. C., Bradley, A., Vallier, L., & Gaffney, D.
- Affiliations
- Wellcome Sanger Institute (GB)
- University of Cambridge (GB)
- Corresponding author
- Gaffney, Daniel
- Venue
- PLoS Genetics
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-06-05
- Volume
- 10
- Issue
- 6
- Pages
- e1004432
- ISSN
- 1553-7390 (ISSN-L)
- 1553-7404
- PMC
- PMC4046971
- OpenAlex
- W2008485310
- Cited by
- 294
- References
- 35
- Citations by year
- 2026: 7 · 2025: 15 · 2024: 22 · 2023: 22 · 2022: 19 · 2021: 29 · 2020: 25 · 2019: 21 · 2018: 33 · 2017: 37 · 2016: 33 · 2015: 25 · 2014: 5
- FWCI
- 13.59
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Genetics (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Apollo (cc-by)
- Funders
- Wellcome Trust (EU-FP7-, 098051)
- NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research
- National Institute for Health and Care Research
- Engineering and Physical Sciences Research Council (TS/H001220/1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- human induced pluripotent stem cells, transcriptional heterogeneity, epigenetic memory, cell line heterogeneity, disease modeling, personalized medicine
- MeSH terms
- Adult, Base Sequence, Cell Differentiation, Cells, Cultured, Female, Fibroblasts, Humans, Male, Transcription, Genetic, Keratinocytes, Sequence Alignment, Sequence Analysis, RNA, Endothelial Cells, Embryonic Stem Cells, Induced Pluripotent Stem Cells, Epigenomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.